I feel privileged to help people and families through some of their most difficult times. I think complete cancer care encompasses not only treating the malignancy, but also guiding the patient and their loved ones through the challenging journey.
Anand P. Shah, MD
Integrated Oncology Program, Radiation Oncology
Years in Practice:
13
years
Practices In:
Lisle
Patients Seen:
Adults
September is prostate cancer awareness month. Since prostate cancer is the second most common form of cancer in men, starting at age 45 for those at an increased risk and age 50 for those at an average risk, screening options are available to help catch cancer at an early stage. Take charge of your health and schedule with your primary care provider to discuss family history and risk factors to determine if screening is right for you.
Locations
Lisle
430 Warrenville Road
Suite 100
Lisle, Illinois 60532
Board Certifications
Radiation Oncology
Languages
English
Awards & Accolades
Chicago Magazine, Top Doctors
2022
Chicago Magazine, Top Doctors
2021
Chicago Magazine, Top Doctors
2020
Chicago Magazine, Top Doctors
2019
Chicago Magazine, Top Doctors
2018
Chicago Magazine, Top Doctors
2017
Selected to Alpha Omega Alpha Medical Honor Society at Northwestern University Medical School
2005
Julie Namkung Research Award for Most Outstanding
2005
Clinical Interests
Cancers of the Lung, Head, Neck, Prostate, Gastrointestinal system, Brain, Breast
Personal Interests
Spending time with my family, Sports, Golf, Basketball
Memberships
American College of Radiation Oncology
American College of Radiology
American Radium Society
American Society of Clinical Oncology
American Society for Radiation Oncology
American Roentgen Ray Society
Association of Residents in Radiation Oncology
Association of University Radiologists
Radiological Society of North America
School
Northwestern University Medical School
Graduation Date:
2005
Degree:
MD
Rush University Graduate College
Graduation Date:
2010
Degree:
MS, Medical Physics
Residency
Rush University Medical Center
Chief Resident
Provider's Contributions
The Care Team Who Supports Your Breast Cancer Treatment
Women's Health,
October 2022
Provider’s Publications
Tomotherapy and IMRT reduce cardiac doses in left-sided breast cancer patients
January 2000
Toxicity Associated with Bowel or Bladder Puncture during Gynecologic Interstitial Brachytherapy
January 2000
Analysis Comparing Electron Beam with the Mammosite for Breast Boost
January 2000
A virtual matching technique for three-field breast irradiation using 3-D planning
January 2000
Tomotherapy and multifield intensity modulated radiotherapy planning reduce cardiac doses in left-sided breast cancer patients with unfavorable cardiac anatomy
January 2000
Variation in Breast Lumpectomy Cavity with Delay Due to Chemotherapy
January 2000
The Role of Radiation Therapy in the Adjuvant Management of Pancreatic Adenocarcinoma
January 2000
Analysis comparing treatment of prostate cancer with TomoTherapy versus IMRT
January 2000
Radiation Recall Reaction with Docetaxel Following Partial Breast Irradiation
January 2000
Management of a patient with borderline resectable pancreatic cancer
January 2000
Case Report of an Axillary Recurrence After Partial Breast Irradiation
January 2000
Upright 3-D Treatment Planning Using a Vertical CT
January 2000
Cost of radiotherapy versus NSAID administration for heteropic ossification
January 2000
Patterns of Failure after MammoSite Brachytherapy Partial Breast Irradiation: A Detailed Analysis
January 2000
Clinical Spectrum and Prevalence of Neurologic Events Provoked By Tilt Table Testing
January 2000
Procedures
Accelerated Fractionation Radiation, Brachytherapy, High-Dose Rate (HDR), Image Guided Radiation Therapy (IGRT), Intensity Modulated Radiation Therapy (IMRT), RapidArc® Radiotherapy, Respiratory Gating, Stereotactic Body Radiation Therapy (SBRT), Stereotactic Radiosurgery (SRS), Stereotactic Radiotherapy (SRT)
Conditions
Breast Cancer, Gastrointestinal Cancer, Genitourinary Cancer, Gynecologic Cancers, Head and Neck Cancer, Lung Cancer, Prostate Cancer, Skin Cancer
Comments